NO864131D0 - Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater.Info
- Publication number
- NO864131D0 NO864131D0 NO864131A NO864131A NO864131D0 NO 864131 D0 NO864131 D0 NO 864131D0 NO 864131 A NO864131 A NO 864131A NO 864131 A NO864131 A NO 864131A NO 864131 D0 NO864131 D0 NO 864131D0
- Authority
- NO
- Norway
- Prior art keywords
- indazol
- indol
- procedure
- preparation
- therapeutic active
- Prior art date
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858525657A GB8525657D0 (en) | 1985-10-17 | 1985-10-17 | Heterocyclic compounds |
GB868609177A GB8609177D0 (en) | 1986-04-15 | 1986-04-15 | Heterocyclic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
NO864131D0 true NO864131D0 (no) | 1986-10-16 |
NO864131L NO864131L (no) | 1987-04-21 |
Family
ID=26289899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO864131A NO864131L (no) | 1985-10-17 | 1986-10-16 | Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater. |
Country Status (13)
Country | Link |
---|---|
US (1) | US4837235A (no) |
EP (1) | EP0227241B1 (no) |
JP (1) | JPH07107047B2 (no) |
AU (1) | AU609704B2 (no) |
CA (1) | CA1335450C (no) |
DE (1) | DE3650567T2 (no) |
DK (1) | DK496086A (no) |
FI (1) | FI864190A (no) |
IE (1) | IE862737L (no) |
IL (1) | IL80336A (no) |
NO (1) | NO864131L (no) |
NZ (1) | NZ217961A (no) |
PT (1) | PT83559B (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY103259A (en) * | 1987-04-15 | 1993-05-29 | Ici America Inc | Aliphatic carboxamides |
US5041460A (en) * | 1988-04-14 | 1991-08-20 | Ici Americas Inc. | Heter-aliphatic carboxamides |
GB8927981D0 (en) * | 1989-12-11 | 1990-02-14 | Ici Plc | Carbamoyl derivative |
DE59103389D1 (de) * | 1990-05-04 | 1994-12-08 | Ciba Geigy Ag | Substituierte Indole. |
DE69109057T2 (de) * | 1990-11-08 | 1995-09-21 | Ciba Geigy Ag | Pyrazol enthaltende Pigmentderivate. |
US5334597A (en) * | 1991-10-17 | 1994-08-02 | Merck Frosst Canada, Inc. | Indole carbamates as leukotriene antagonists |
EP0539330B1 (de) * | 1991-10-25 | 1995-05-17 | Ciba-Geigy Ag | Verfahren zur Herstellung substituierter Indole |
EP0539329A1 (de) * | 1991-10-25 | 1993-04-28 | Ciba-Geigy Ag | Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten |
US5280039A (en) * | 1992-11-04 | 1994-01-18 | Pfizer Inc. | Bicyclic carbamates and methods of treating inflammatory diseases using the same |
US5439929A (en) * | 1994-03-01 | 1995-08-08 | Pfizer Inc. | Bicyclic carbamates, pharmaceutical compositions and use |
WO2001007031A1 (fr) * | 1999-07-26 | 2001-02-01 | Shionogi & Co., Ltd. | Derives de benzene, compositions immunostimulantes ou agents de retablissement de la pharmacosensibilite les contenant |
EP1904452A2 (en) | 2005-07-14 | 2008-04-02 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
BRPI0614340A2 (pt) | 2005-08-17 | 2011-04-12 | Wyeth Corp | indóis substituìdos e métodos de seu uso |
JP5298008B2 (ja) * | 2006-04-20 | 2013-09-25 | グラクソ グループ リミテッド | 新規化合物 |
WO2010051561A1 (en) * | 2008-11-03 | 2010-05-06 | Chemocentryx, Inc. | Compounds for the treatment of osteoporosis and cancers |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT234103B (de) * | 1959-09-03 | 1964-06-10 | Merck & Co Inc | Verfahren zur Herstellung von neuen, benzylindolylsubstituierten niedrigen aliphatischen Säuren sowie deren Salzen und Estern |
US3271416A (en) * | 1961-10-24 | 1966-09-06 | Merck & Co Inc | Indolyl aliphatic acids |
FR4035M (no) * | 1964-11-04 | 1966-03-28 | ||
US3470298A (en) * | 1969-01-29 | 1969-09-30 | Acraf | Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids |
DE2854987A1 (de) * | 1978-12-20 | 1980-06-26 | Boehringer Mannheim Gmbh | Diagnostische mittel zum nachweis proteolytischer enzyme und dafuer geeignete chromogene |
US4499299A (en) * | 1981-12-30 | 1985-02-12 | Ici Americas Inc. | Pharmaceutically active phenylcarboxylic acid derivatives |
CA1241660A (en) * | 1984-06-25 | 1988-09-06 | Yvan Guindon | Indole-2-alkanoic acids |
GB8524157D0 (en) * | 1984-10-19 | 1985-11-06 | Ici America Inc | Heterocyclic amides |
GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
GB8623429D0 (en) * | 1985-10-17 | 1986-11-05 | Ici America Inc | Carboximide derivatives |
GB8707051D0 (en) * | 1986-04-15 | 1987-04-29 | Ici America Inc | Heterocyclic carboxamides |
-
1986
- 1986-10-16 DK DK496086A patent/DK496086A/da unknown
- 1986-10-16 US US06/919,781 patent/US4837235A/en not_active Expired - Fee Related
- 1986-10-16 NZ NZ217961A patent/NZ217961A/xx unknown
- 1986-10-16 PT PT83559A patent/PT83559B/pt not_active IP Right Cessation
- 1986-10-16 DE DE3650567T patent/DE3650567T2/de not_active Expired - Fee Related
- 1986-10-16 JP JP61244324A patent/JPH07107047B2/ja not_active Expired - Fee Related
- 1986-10-16 AU AU63986/86A patent/AU609704B2/en not_active Ceased
- 1986-10-16 IL IL80336A patent/IL80336A/xx unknown
- 1986-10-16 IE IE862737A patent/IE862737L/xx unknown
- 1986-10-16 EP EP86308053A patent/EP0227241B1/en not_active Expired - Lifetime
- 1986-10-16 FI FI864190A patent/FI864190A/fi not_active Application Discontinuation
- 1986-10-16 NO NO864131A patent/NO864131L/no unknown
- 1986-10-17 CA CA000520793A patent/CA1335450C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU609704B2 (en) | 1991-05-09 |
PT83559B (pt) | 1989-05-31 |
JPS6296465A (ja) | 1987-05-02 |
EP0227241A3 (en) | 1988-08-03 |
DE3650567T2 (de) | 1997-02-20 |
NO864131L (no) | 1987-04-21 |
DK496086D0 (da) | 1986-10-16 |
EP0227241A2 (en) | 1987-07-01 |
CA1335450C (en) | 1995-05-02 |
FI864190A0 (fi) | 1986-10-16 |
PT83559A (en) | 1986-11-01 |
IL80336A (en) | 1990-02-09 |
NZ217961A (en) | 1990-06-26 |
EP0227241B1 (en) | 1996-09-11 |
JPH07107047B2 (ja) | 1995-11-15 |
AU6398686A (en) | 1987-04-30 |
DK496086A (da) | 1987-04-18 |
FI864190A (fi) | 1987-04-18 |
DE3650567D1 (de) | 1996-10-17 |
US4837235A (en) | 1989-06-06 |
IE862737L (en) | 1987-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
NO853046L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. | |
NO870075L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. | |
NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
NO883974D0 (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
NO894630D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
NO870526D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
NO165023C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol- og furan derivater. | |
NO862956D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater. | |
NO874032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
NO864674D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser. | |
NO162721C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridinderivater. | |
NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
NO863671L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler. | |
NO864130L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater. | |
NO864131D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater. | |
NO875488D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
NO861584L (no) | Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere. | |
NO891723L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO167284C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksazol- og isoksazolderivater. | |
NO865012L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzazepin-derivater. | |
NO864101D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. |